Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 3Phase 3 1Phase 1/2 1

Status

Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2

Conditions

Polycystic Ovary Syndrome 3Prostatic Neoplasms 2Ovarian Hyperstimulation Syndrome 2Infertility 2Myofibroma 1Hodgkin Disease 1

Interventions

Metformin 52Inositol 22Clomiphene 17Letrozole 16Exercise 14High-Intensity Interval Training 10Folic Acid 10Caloric Restriction 10Progesterone 8Ethinyl Estradiol 8Estradiol 7Diet 6drospirenone 5drospirenone and ethinyl estradiol combination 4Tablets 4In Vitro Oocyte Maturation Techniques 4Estrogens 4Diet, Mediterranean 4Cyproterone Acetate 4Control Groups 4Berberine 4Acupuncture Therapy 4Vitamin D 3Triptorelin Pamoate 3Thioctic Acid 3Spironolactone 3Resistance Training 3Pioglitazone 3Medroxyprogesterone Acetate 3Lactalbumin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Polycystic Ovary Syndrome × Triptorelin Pamoate × Clear all
NCT05112692 2021-11-09

Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles

Mansoura University

Phase NA Unknown
200 enrolled

Polycystic Ovary Syndrome

NCT02022228 2013-12-27

Dual Trigger to Reduce Ovarian Hyperstimulation Syndrome

Nanfang Hospital, Southern Medical University

Phase NA Unknown
200 enrolled
Gynecologic

Infertility, Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome

NCT02022241 2013-12-27

Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome

Nanfang Hospital, Southern Medical University

Phase NA Unknown
80 enrolled
Gynecologic

Infertility, Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡